• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

Disease profile with its updated diagnostic assay in Leprosy patients attending IGIMS, Patna: A tertiary care hospital of Bihar

    Dr Samir Alam, Dr.Rakesh Kumar, Dr. Kamlesh Rajpal, Dr. Sweta Muni, Dr. Rajesh Sinha, Dr. Shailesh Kumar, Dr. Namrata kumara, Dr. Sweta Muni

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 5384-5395

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction: Leprosy is considered a public health issue in countries where the annual
prevalence rate is greater than 1 case per 10,000 inhabitants. It is endemic in several
countries with low levels of social and economic development, especially India, with the
highest absolute number of cases in the former. In 2018, 208,619 new leprosy cases were
registered worldwide by the World Health Organization (WHO).
Aims & Objectives: to assess bacteriological index in these sample, to correlate these
findings with the newer techniques(ELIZA)m
Data and methods: A total of 106patients selected who were attending General
Medicine Department & V.D. Department at IGIMS, Patna and investigated at
Microbiology Department for slit skin smear examination. Blunt, narrow scalpel was
introduced into the nose and a piece of mucous membrane was taken for nasal smear
examination. The smears were examined under oil immersion lens to see red AFB
arranged singly or in groups / bundles (Globi).
Results: The most common form of leprosy observed in the present study was
borderline leprosy (BB) and Lepromatous leprosy (LL). Both the forms constituted
equal proportion of patients (24.5%). The sensitivity and specificity of ELISA was
48.42% and 72.73% respectively.
Conclusions: It was found that sensitivity; specificity, positive predictive value, and
negative predictive value of enzyme-linked immunosorbent assay (ELISA)
Keywords:
  • PDF (420 K)
  • XML
(2022). Disease profile with its updated diagnostic assay in Leprosy patients attending IGIMS, Patna: A tertiary care hospital of Bihar. European Journal of Molecular & Clinical Medicine, 9(3), 5384-5395.
Dr Samir Alam, Dr.Rakesh Kumar, Dr. Kamlesh Rajpal, Dr. Sweta Muni, Dr. Rajesh Sinha, Dr. Shailesh Kumar, Dr. Namrata kumara, Dr. Sweta Muni. "Disease profile with its updated diagnostic assay in Leprosy patients attending IGIMS, Patna: A tertiary care hospital of Bihar". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 5384-5395.
(2022). 'Disease profile with its updated diagnostic assay in Leprosy patients attending IGIMS, Patna: A tertiary care hospital of Bihar', European Journal of Molecular & Clinical Medicine, 9(3), pp. 5384-5395.
Disease profile with its updated diagnostic assay in Leprosy patients attending IGIMS, Patna: A tertiary care hospital of Bihar. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 5384-5395.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 110
  • PDF Download: 113
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus